Overview
IRTC market data
Price History
IRTC price chart
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$1.39 Diluted earnings per share over the trailing twelve months.
- Beta
- 1.45 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- -3.5% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $100.85 – $212.00 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $4.1B · P/B 37.43 · P/S 5.22.
Company News
8-K filing — iRhythm Holdings, Inc. (IRTC)SEC EDGAR · Aug 13, 2026, 8:15 PM
Truist Securities Maintains Buy on iRhythm Holdings, Raises Price Target to $168Benzinga · Aug 10, 2026, 6:23 PM
iRhythm Combines Strong Performance with VitalConnect Buy to Expand Remote Cardiac CareBenzinga · Aug 7, 2026, 2:47 PM
Wells Fargo Maintains Overweight on iRhythm Holdings, Lowers Price Target to $168Benzinga · Aug 7, 2026, 2:13 PM
Needham Maintains Buy on iRhythm Holdings, Lowers Price Target to $192Benzinga · Aug 7, 2026, 1:35 PM
Evercore ISI Group Maintains Outperform on iRhythm Holdings, Raises Price Target to $165Benzinga · Aug 7, 2026, 12:40 PM
iRhythm To Acquire Maker Of Wearable Biosensor And Ambulatory Cardiac Monitoring Technology Vital Connect For ~$237.5M In Cash And ~$50M In IRTC StockBenzinga · Aug 6, 2026, 8:40 PM
iRhythm Holdings Raises FY2026 Sales Guidance from $875.000M-$885.000M to $880.000M-$890.000M vs $881.129M EstBenzinga · Aug 6, 2026, 8:14 PM
iRhythm Technologies Q2 Adj. EPS $0.58 Beats $(0.00) Estimate, Sales $224.172M Beat $219.324M EstimateBenzinga · Aug 6, 2026, 8:06 PM
Stephens & Co. Initiates Coverage On iRhythm Holdings with Overweight Rating, Announces Price Target of $160Benzinga · Jul 23, 2026, 6:46 PM